Mountain Valley MD Holdings Provides Business Update
TORONTO, April 28, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
TORONTO, April 28, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
LONDON and PHOENIX, April 28, 2022 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTCQB: ACUT), a…
FREMONT, CA, April 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ:…
New Position Aimed at Attracting, Retaining, and Cultivating a Best-in-Class Workforce as Allogene Scales its…
BOSTON, April 28, 2022 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical…
Follow up ILUVIEN® PALADIN data to be presented onsite at the annual Association for Research…
LEXINGTON, Mass., April 28, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
MIAMI, April 28, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company, today…
MALVERN, Pa., April 28, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
Report Highlights Efforts to Deliver Long-term Sustainable Value for Patients and Communities and Advance Diversity,…
SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Company expects to launch pivotal Phase 3 ASCEND clinical trial to evaluate TMB-001 within the…
BASKING RIDGE, N.J., April 28, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
CAMBRIDGE, Mass., April 28, 2022 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage…
FORT LAUDERDALE, Fla., April 28, 2022 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
Based on positive feedback provided by FDA on key clinical design details Jasper plans to…
BOSTON and JERUSALEM, April 28, 2022 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a…
CONSHOHOCKEN, Pa., April 28, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage…
FLORHAM PARK, N.J., April 28, 2022 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
SYDNEY, AUSTRALIA, April 28, 2022 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or…